Compare TNYA & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNYA | LEE |
|---|---|---|
| Founded | 2016 | 1890 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 178.5M | 160.1M |
| IPO Year | 2021 | 2025 |
| Metric | TNYA | LEE |
|---|---|---|
| Price | $0.74 | $8.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $5.33 | N/A |
| AVG Volume (30 Days) | ★ 5.2M | 110.1K |
| Earning Date | 03-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.96 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $543,955,000.00 |
| Revenue This Year | N/A | $5.48 |
| Revenue Next Year | $1,456.12 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.36 | $3.34 |
| 52 Week High | $2.35 | $10.88 |
| Indicator | TNYA | LEE |
|---|---|---|
| Relative Strength Index (RSI) | 47.51 | 50.18 |
| Support Level | $0.61 | $3.77 |
| Resistance Level | $0.75 | $9.74 |
| Average True Range (ATR) | 0.10 | 0.71 |
| MACD | -0.01 | -0.23 |
| Stochastic Oscillator | 33.90 | 23.59 |
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.